Xanamem Research Published in Prestigious Medical Journal
Filed with ASX · · 2 pages · English
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Appendix 4C - quarterly
- FDA Approval to Commence Alzheimers Disease Clinical Trial
- Significant Advance in Development of Alzheimers Drug
- FDA Feedback on Xanamem Alzheimers Trail
- R&D Tax Rebate
Later from Actinogen Medical
- UK Regulatory Approval for Alzheimers Clinical Trial-XanADu
- Actinogen Medical Financial Results
- TGA Regulatory Approval for Alzheimers Phase II Trial
- March Quarterly Update
- First Patient Treated in Landmark Alzheimers Clinical Trial
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical